CCSME logo
This course is open to anyone interested — not just prescribers.

The goal of this training is to acquire the knowledge and skills needed
to provide optimal care to opioid use disorder patients.

So if you're curious, be sure to join us!
for Prescribing Buprenorphine
Drs. Leah Bauer, MD; Kristen B. Silvia, MD;  & Leora Cohen-McKeon, DO
The “Drug Addiction Treatment Act of 2000” created the opportunity to expand treatment for opioid use disorder into the mainstream of medical practice, increase the number of persons treated, and have an important positive public health impact.

The legislation specifies several ways in which physicians can be considered qualified to prescribe and dispense buprenorphine in their offices for the treatment of opioid use disorder.

Designated by the US DHHS, this training meets the 8-hour requirement and is designed for prescribers to dispense buprenorphine in office practice for treatment of opioid use disorder.
10.28.16 | Brunswick
8 contact hours •  $50
About the "Half and Half" Course

The "Half and Half" course includes both online and face-to-face components. The first "half" of this course consists of 3.75 hours of self-guided online training, including five modules and a required examination. After completing the first "half" of the course and successfully passing the examination, you must attend the second "half" of the course. The second "half" of the course consists of 4.25 hours of live face-to-face training.

Information on accessing and completing the online portion of the training
will be emailed upon registration for this event.
Dr. Leah Bauer, MD is a psychiatrist and Medical Director of the Addiction Resource Center at Mid Coast Hospital in Brunswick. She has a strong interest in medication assisted treatment of substance use disorders and has led several buprenorphine x-waiver trainings as well as spoken at national meetings on these issues. She is also interested in addiction as it relates to trauma and women’s specific issues.
Kristen B. Silvia, MD is the Primary Care Champion for Maine Medical Center’s new Integrated Medication Assisted Therapy (IMAT) Program. Dr. Silvia became interested in treating patients with substance use disorders while in residency and has been a provider of buprenorphine therapy for the treatment of opiate dependence to more than 120 patients over the past 10 years.
Leora Cohen-McKeon, DO is a family medicine physician in Portland Maine at Martins Point Health Care. She has been practicing medicine since 2009. She has a specialty in women's health care and provides care for opioid dependence. She has been prescribing buprenorphine for 7 years alongside her general medicine practice.

Funding for this initiative was made possible (in part) by Providers’ Clinical Support System for Medication Assisted Treatment (1U79TI026556) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of University of New England College of Osteopathic Medicine (UNECOM) and CCSME. UNECOM is accredited by the Maine Medical Association Council on Continuing Medical Education and Accreditation to provide continuing medical education for physicians.
This training is funded in part by the Maine Behavioral Health Workforce Development Collaborative, a partnership between AdCare Educational Institute of Maine, Co-Occurring Collaborative Serving Maine, and Muskie School of Public Service with funding from the Maine Office of Substance Abuse and Mental Health Services (SAMHS), Department of Health and Human Services.
For a full listing of CCSME events, please visit our website.